Home / Clinical trials / Sermorelin
Are there clinical trials for Sermorelin?
Sermorelin has 27 registered clinical trials, including 19 completed interventional studies and trials reaching Phase 4. Its use in humans is supported by established registered clinical evidence.
Trial breakdown
By phase
| Not applicable | 8 |
| Phase 2 | 7 |
| Phase 1 | 5 |
| Phase 3 | 4 |
| Phase 4 | 1 |
By status
| Completed | 21 |
| Terminated | 3 |
| Unknown status | 1 |
| Withdrawn | 1 |
| Recruiting | 1 |
Active trials
- Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIVPhase 2 · Recruiting · 100 participants · Massachusetts General Hospital · started 2025-07-10NCT06554717
Most recent registered trials
- Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIVPhase 2 · Recruiting · 100 participants · Massachusetts General Hospital · started 2025-07-10NCT06554717
- Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular RiskPhase 2 · Completed · 51 participants · Massachusetts General Hospital · started 2019-01-17NCT03375788
- The Effect of Growth Hormone Releasing Hormone on Cognitive Function in Individuals With Mild Cognitive ImpairmentPhase 1 · Completed · 22 participants · The University of Texas Medical Branch, Galveston · started 2017-07-18NCT02553603
- Study of Intranasal Octreotide (DP1038) in Healthy Adult VolunteersPhase 1 · Completed · 32 participants · Dauntless Pharmaceuticals · started 2017-01NCT03031535
- Dehydroepiandrosterone Versus Growth Hormone in Women Undergoing ICSI With Expected Poor Ovarian ResponsePhase 3 · Unknown status · 210 participants · Cairo University · started 2016-06NCT02736591
- Tesamorelin Effects on Liver Fat and Histology in HIVNot applicable · Completed · 61 participants · Massachusetts General Hospital · started 2015-07-01NCT02196831
- Estradiol-Receptor Blockade in Older Men and WomenPhase 1 · Completed · 40 participants · Mayo Clinic · started 2014-12NCT02271282
- Observational Longitudinal Study in Children Affected by Idiopathic Growth Hormone Deficiency (GHD)Completed · 48 participants · Stefania La Grutta, MD · started 2014-01NCT02507245
- Abdominal Obesity, Cardiovascular Inflammation, and Effects of Growth Hormone Releasing Hormone AnalogueNot applicable · Withdrawn · Massachusetts General Hospital · started 2014-01NCT01632592
- Three Month Treatment of Growth Hormone Releasing Hormone (GHRH) in the ElderlyPhase 2 · Terminated · 13 participants · University of Pennsylvania · started 2011-05NCT01410799
- VRS-317 in Adult Subjects With Growth Hormone DeficiencyPhase 1 · Completed · 50 participants · Versartis Inc. · started 2011-03NCT01359488
- Effects of Growth Hormone Releasing Hormone in HIVNot applicable · Completed · 54 participants · Massachusetts General Hospital · started 2010-12NCT01263717
Frequently asked questions
Are there clinical trials for Sermorelin?
Sermorelin has 27 registered clinical trials, including 19 completed interventional studies and trials reaching Phase 4. Its use in humans is supported by established registered clinical evidence.
Does a registered trial mean the peptide works?
No. Registration means a study was formally listed before or during the research. It says nothing about the result. A completed trial can find no benefit, and many registered studies are never published.
What is the difference between a registered trial and published evidence?
Registration records that a study exists. Publication reports what it found. This page counts registrations, which is the more complete picture of research activity, but it is not a measure of proven effectiveness.
Why do phases matter?
Phase 1 tests safety in a small group. Phase 2 looks for early signs of effect. Phase 3 tests effectiveness against a comparator in a large group, and is what regulators normally require. Phase 4 studies happen after approval. A compound with only Phase 1 trials has not been shown to work.
Source: ClinicalTrials.gov API v2, U.S. National Library of Medicine. Studies where Sermorelin is registered as an intervention. Last updated 2026-09-23.